Characteristic
RAVI/LAVI Q1 (<0.620) (n=29) RAVI/LAVI Q2 (0.620-0.840) (n=28) RAVI/LAVI Q3 (0.840-1.120) (n=28) RAVI/LAVI Q4 (≥1.120) (n=28)
p-value
 Age  59.8 ± 15.2 63.3 ± 12.0 56.1 ± 17.6 60.8 ± 14.5 0.755
Female Sex 7 (24.1) 7 (25.0) 12 (42.9) 7 (25.0) 0.339
Coronary Artery Disease 21 (72.4) 20(71.4) 15 (53.6) 16 (57.1) 0.329
Type 2 Diabetes Mellitus 18 (62.1) 16 (57.1) 12 (42.9) 10 (35.7) 0.164
Chronic Kidney Disease 13 (44.8) 11 (39.3) 14 (50.0) 13 (46.4) 0.879
Chronic Obstructive Pulmonary Disease 8 (27.6) 8 (28.6) 7 (25.0) 3 (10.7) 0.350
Hypertension 19 (65.5) 17 (60.7) 14 (50.0) 18 (64.3) 0.625
Hyperlipidemia 16 (55.2) 17 (60.7) 17 (60.7) 19 (67.9) 0.809
Tobacco Abuse 19 (65.5) 18 (64.3) 15 (53.6) 18 (64.3) 0.772
Beta Blocker 18 (62.1) 16 (57.1) 20 (71.4) 18 (64.3) 0.733
ACEi* / ARB† 14 (48.3) 12 (42.9) 12 (42.9) 15 (53.6) 0.930
Aldosterone Antagonist 8 (27.6) 7 (25.0) 10 (35.7) 7 (25.0) 0.785
Diuretic 21 (72.4) 17 (60.7) 21 (75.0) 22 (78.6) 0.480
Home Inotrope 3 (10.3) 1 (3.6) 3 (10.7) 4 (14.3) 0591
Admission Lactic Acid 2.4 ± 2.1 3.5 ± 2.7 2.6 ± 1.6 3.4 ± 2.3 0.314
Admission Brain Natriuretic Peptide 1743.2 ± 1343.9 1608.9 ± 1014.2 2454.2 ± 1919.0 3954.2 ± 1455.2 0.020
Admission Creatinine 1.6 ± 0.9 1.9 ± 1.2 1.8 ± 1.0 2.1 ± 1.1 0.198